A service of StreetInsider.com
Welcome

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

SLAT 0.67
LNT 25.80
NDN 26.28
HTD 10.23
AGCO 29.88

Gaining Speed

SAPE 6.13
ACCP 2.20
XYNH 0.01
CSG 45.46
HTD 10.23
25.08 +9.60 (38.34%) PRX

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:25.08 Change:+9.60 (38.34%) Prev Close:15.48 Open: 25.04 Days Range:25.00 – 29.98 52 Week Range: 7.80 - 18.26 Volume:444270 P/E: N/A
EPS:-0.98

Member Comments

No member comments available for PRX


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/03/09

Recent Alert on 05/06/09 at 10:01am
Morning Movers 5/6: SBGI, ACOR, ARM, LINC, MPG Higher; ABD, ACAS, ALY, BBND, DENN Lower

Sinclair Broadcast Group (Nasdaq: SBGI) 42.3% HIGHER; reports Q1 adj-EPS of $0.19, versus the analyst estimate of ($0.05). Revenue for the quarter was $131.3 million, versus the consensus of $141.73 million. Acorda Therapeutics (Nasdaq: ACOR)... Read More

Recent Alert on 05/06/09 at 7:52am
Par Pharma (PRX) Reports Strong Q1 Results
Recent Alert on 04/28/09 at 7:35am
Goldman Sachs Downgrades Par Pharmaceutical (PRX) to Sell
Recent Alert on 04/23/09 at 8:13am
RBC Initiates Coverage on Several Drug Makers

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 07/02/09 at 9:43am
Form 4 SMITH JOSEPH E For: Jul 01
SEC Filing on 07/02/09 at 9:34am
Form 4 SHAROKY MELVIN MD For: Jul 01
SEC Filing on 07/02/09 at 9:25am
Form 4 KNIGHT PETER S For: Jul 01

View AllRecent Blog Posts

Blog Posts on 06/24/09 at 10:30am
Santarus: Business Fundamentals Are Unchanged
Blog Posts on 06/16/09 at 4:25am
FDA Calendar Updates: Transdel, Javelin, Jazz, Par Pharma
Blog Posts on 06/11/09 at 3:35am
FDA Calendar Updates: Trinity Biotech Awaiting Two Responses
Blog Posts on 06/05/09 at 6:26am
Emisphere: Improving Drug Delivery
Blog Posts on 04/12/09 at 3:39am
How Will Cardiome, Merck, Eli Lilly, and Par Pharma's Phase 3 Trials Perform?